These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 15851489)

  • 1. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.
    Pascual V; Allantaz F; Arce E; Punaro M; Banchereau J
    J Exp Med; 2005 May; 201(9):1479-86. PubMed ID: 15851489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade.
    Allantaz F; Chaussabel D; Stichweh D; Bennett L; Allman W; Mejias A; Ardura M; Chung W; Smith E; Wise C; Palucka K; Ramilo O; Punaro M; Banchereau J; Pascual V
    J Exp Med; 2007 Sep; 204(9):2131-44. PubMed ID: 17724127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking IL-1 in systemic inflammation.
    Dinarello CA
    J Exp Med; 2005 May; 201(9):1355-9. PubMed ID: 15867089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma interleukin-37 is increased and inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells in systemic juvenile idiopathic arthritis patients.
    Feng M; Kang M; He F; Xiao Z; Liu Z; Yao H; Wu J
    J Transl Med; 2018 Oct; 16(1):277. PubMed ID: 30305171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
    Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Isupova EA; Kuchinskaya EM; Glebova NI; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
    Pediatr Rheumatol Online J; 2015; 13():4. PubMed ID: 25685108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis.
    Kessel C; Lippitz K; Weinhage T; Hinze C; Wittkowski H; Holzinger D; Fall N; Grom AA; Gruen N; Foell D
    Arthritis Rheumatol; 2017 Jul; 69(7):1480-1494. PubMed ID: 28296284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Effects of Interleukins on the Pathogenesis of Systemic Onset Juvenile Idiopathic Arthritis.
    Xu LY; Zhang WM; Xia M; Cao LF
    Pediatr Neonatol; 2016 Oct; 57(5):396-401. PubMed ID: 26810447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
    Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
    Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and significance of interleukin-6, interferon-inducible protein-10 and interleukin-17 in serum and synovial fluid of patients with juvenile idiopathic arthritis].
    Li RJ; Tang XM; Liu W; Zhou J; An YF; Qin SY; Zou ZY
    Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):472-6. PubMed ID: 24120067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA).
    Hedrich CM; Bruck N; Fiebig B; Gahr M
    Rheumatol Int; 2012 Nov; 32(11):3525-30. PubMed ID: 22083619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils.
    Xing L; Remick DG
    Shock; 2003 Jul; 20(1):10-6. PubMed ID: 12813362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic-onset juvenile idiopathic arthritis.
    Cimaz R
    Autoimmun Rev; 2016 Sep; 15(9):931-4. PubMed ID: 27392503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum levels of Th1/Th2 cytokines in children with non-systemic juvenile idiopathic arthritis].
    Lijiao J; Meiping LU; Li G; Jianqiang WU; Lixia Z; Yiping XU
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(3):281-6. PubMed ID: 27651193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
    Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
    Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anakinra therapy in a child with systemic-onset juvenile rheumatoid arthritis after human herpesvirus 6 encephalitis.
    Mirkinson LJ; Nagle D; Kadom N; Jones OY
    J Clin Rheumatol; 2006 Apr; 12(2):83-6. PubMed ID: 16601542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor downregulates inflammatory response in human monocytes through TrkA.
    Prencipe G; Minnone G; Strippoli R; De Pasquale L; Petrini S; Caiello I; Manni L; De Benedetti F; Bracci-Laudiero L
    J Immunol; 2014 Apr; 192(7):3345-54. PubMed ID: 24585880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study.
    Vastert SJ; de Jager W; Noordman BJ; Holzinger D; Kuis W; Prakken BJ; Wulffraat NM
    Arthritis Rheumatol; 2014 Apr; 66(4):1034-43. PubMed ID: 24757154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of extracellular histones in systemic-onset juvenile idiopathic arthritis.
    Hu X; Xie Q; Mo X; Jin Y
    Ital J Pediatr; 2019 Jan; 45(1):14. PubMed ID: 30642364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report.
    Iacono A; Sprocati M; Giuliani AL; Di Virgilio F; Borgna-Pignatti C; Maggiore G
    Ital J Pediatr; 2019 Jun; 45(1):73. PubMed ID: 31234906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients With Systemic-Onset Juvenile Idiopathic Arthritis.
    Ter Haar NM; Tak T; Mokry M; Scholman RC; Meerding JM; de Jager W; Verwoerd A; Foell D; Vogl T; Roth J; Leliefeld PHC; van Loosdregt J; Koenderman L; Vastert SJ; de Roock S
    Arthritis Rheumatol; 2018 Jun; 70(6):943-956. PubMed ID: 29426067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.